Apricus Biosciences to Present at the Rodman & Renshaw 17th Annual Global Investment Conference
.



Apricus Biosciences, Inc. 15 minutes ago GlobeNewswire










.
ˠ
➕
✕
.
.

....
.
..
..










.
.

Related Quotes
.



APRI1.78+4.71%






Apricus Biosciences, Inc. Watchlist

1.78+0.08(+4.71%)

NASDAQTue, Sep 1, 2015 4:00 PM EDT



Apricus Biosciences (APRI) Looks Good: Stock Gains 9.8%
Zacks 1 day 21 hrs ago

5 Big FDA Decisions Expected in September
24/7 Wall St. q 3 days ago


More
.
SAN DIEGO, Sept. 2, 2015 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (APRI), a biopharmaceutical company advancing innovative medicines in urology and rheumatology, today announced that Richard Pascoe, Chief Executive Officer, will present at the Rodman & Renshaw 17th Annual Global Investment Conference on Thursday, September 10, 2015, at 4:40 p.m. Eastern Time. The conference will be held at The St. Regis Hotel, New York, NY. Mr. Pascoe will provide an update on Vitaros(R), the Company's topical treatment for erectile dysfunction, as well as Apricus' drug candidates fispemifene, for the treatment of men with secondary hypogonadism and RayVa(TM), for the treatment of patients with Raynaud's phenomenon.

A live audio webcast of the presentation can be accessed via the Investor Relations section of the Company's website at www.apricusbio.com. Please log in approximately 5-10 minutes before the event to ensure a timely connection. A replay of the webcast will be available for 90 days following the presentation.